Brief: Medigene Q1 Net Loss Of EUR 5.7 Mln

Medigene AG

14/05/2019 06:38

May 14 (Reuters) - MEDIGENE AG  MDG1k.DE :
    * Q1 EBITDA LOSS INCREASED AS PLANNED BY 31% TO EUR 5.0 M
DUE TO
PROGRESS IN IMMUNOTHERAPY PROGRAMS
    * Q1 NET LOSS FOR PERIOD INCREASED AS PLANNED BY 36% TO EUR
5.7 M
    * IMPROVES ITS REVENUE GUIDANCE AND EXPECTS TO GENERATE
TOTAL
REVENUES OF BETWEEN EUR 10 - 11 M (PREVIOUS GUIDANCE: EUR 5.5 -
6.5 M) IN 2019
    * CONTINUES TO EXPECT RESEARCH AND DEVELOPMENT EXPENSES OF
EUR 24
-29 M IN 2019
    * ALSO CONFIRMS ITS EBITDA-GUIDANCE AND CONTINUES TO EXPECT
A LOSS
AT EBITDA LEVEL OF EUR 23 - 28 M

Source text for Eikon:  ID:nPexJKPFGa 
Further company coverage:  MDG1k.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))